期刊文献+

SREBP-1C、GRP-94在非酒精性脂肪肝中的表达及意义 被引量:5

Expressions of SREBP-1C and GRP-94 in human nonalcoholic fatty liver
下载PDF
导出
摘要 目的探讨非酒精性脂肪肝中肝细胞固醇调节元件结合蛋白(SREBP-1C)与葡萄糖调节蛋白94(GRP-94)的表达变化,评价内质网应激蛋白对肝细胞脂质代谢的影响。方法应用半定量逆转录聚合酶链反应(RT-PCR)法和免疫组织化学法检测18例非酒精性脂肪肝患者和10例正常对照肝组织中SREBP-1C与GRP-94基因和蛋白表达,肝活检评分其炎症和纤维化。结果与正常对照组比较,非酒精性脂肪肝患者肝组织SREBP-1c与GRP-94基因和蛋白表达明显增强(P<0.01)。结论非酒精脂肪肝引起的肝脏损害可能与SREBP-1c和GRP-94表达有关,它们参与脂肪肝的发生,这可能是该病的发病机制之一。 【Objective】 To explore the expressions of sterol regulatory element binding protein-1C(SREBP-1C) and glucose-regulated protein 94(GRP-94) in human nonalcoholic fatty liver(NAFLD) and to evaluate the effects of endoplasmic reticulum stress proteins on hepatocytes lipids metabolism. 【Methods】 The expressions of SREBP-1C and GRP-94 in hepatic tissues were assessed in 24 patients with NAFLD and 8controls without liver disease using the RT-PCR and immunohistomistry. Liver biopsies were also graded for inflammation and fibrosis. 【Results】 A significant elevation in the expressions of SREBP-1C and GRP-94 in liver of NAFLD group were found compared to the control group(P〈0.01). 【Conclusion】 The excessive expressions of SREBP-1C and GRP-94 could participate in the development of nonalcoholic fatty liver. This information suggested that was involved in mechanism of nonalcoholic fatty liver.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第17期23-27,共5页 China Journal of Modern Medicine
  • 相关文献

参考文献20

  • 1TUYAMA AC, CHANG CY. Non-alcoholic fatty liver disease[J]. J Diabetes, 2012, 4(3): 266-280. 被引量:1
  • 2MUSSO G, CASSADER M, ROSINA F, et al. Impact of erarent treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review amd meta-analysis of randomised trials[J]. Diabetologia, 2012, 55(4): 885-904. 被引量:1
  • 3WANG J, CHIU WH, CHEN RC, et al. The clinical investigation of disparity of nonalcoholic fatty liver disease in a chinese occupational population in Taipei, Taiwan: experience at a teaching hospital[J]. Asia Pac J Public Health, 2013. 被引量:1
  • 4BAFFY G, BRUNT E M, CALDWELL SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace[J].J Hepatol, 2012, 56(6): 1384-1391. 被引量:1
  • 5TABAS I, RON D. Integrating the mechanisms of apoptosis in- duced by endoplasmic reticulum stress[J]. Nat Cell Biol, 2011, 13(3): 184-190. 被引量:1
  • 6PARMAR VM, SCHRODER M. Sensing endoplasmic reticulum stress[J]. Adv Exp Med Biol, 2012, 738: 153-168. 被引量:1
  • 7CHALASANI N, YOUNOSSI Z, LAVINE JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association[J]. Hepatology, 2012, 55(6): 2005- 2023. 被引量:1
  • 8VALENTI L, MENDOZA RM, RAMETTA R, et al. Hepatic Notch Signaling Correlates with Insulin Resistance and Non-Al- coholic Fatty Liver Disease[J]. Diabetes, 2013. 被引量:1
  • 9BIRKENFELD AL, SHULMAN GI. Non alcoholic fatty liver disease, hepatic insulin resistance and type 2 diabetes[J]. Hepatology, 2013. 被引量:1
  • 10VAN DE WIER B, BALK JM, HAENEN GR, et al. Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production[J]. FEBS Lett, 2013, 587(15): 2461-2466. 被引量:1

同被引文献52

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部